User profiles for Sangeeta Bhatia

Sangeeta N. Bhatia

- Verified email at mit.edu - Cited by 76591

Sangeeta Bhatia

- Verified email at ukhsa.gov.uk - Cited by 11309

Microfluidic organs-on-chips

SN Bhatia, DE Ingber - Nature biotechnology, 2014 - nature.com
An organ-on-a-chip is a microfluidic cell culture device created with microchip manufacturing
methods that contains continuously perfused chambers inhabited by living cells arranged …

Microscale culture of human liver cells for drug development

SR Khetani, SN Bhatia - Nature biotechnology, 2008 - nature.com
Tissue function depends on hierarchical structures extending from single cells (∼10 μm) to
functional subunits (100 μm–1 mm) that coordinate organ functions. Conventional cell culture …

Nanoparticles that communicate in vivo to amplify tumour targeting

…, WE Berdel, E Ruoslahti, MJ Sailor, SN Bhatia - Nature materials, 2011 - nature.com
Nanomedicines have enormous potential to improve the precision of cancer therapy, yet our
ability to efficiently home these materials to regions of disease in vivo remains very limited. …

Probing the cytotoxicity of semiconductor quantum dots

AM Derfus, WCW Chan, SN Bhatia - Nano letters, 2004 - ACS Publications
With their bright, photostable fluorescence, semiconductor quantum dots (QDs) show
promise as alternatives to organic dyes for biological labeling. Questions about their potential …

[HTML][HTML] Estimates of the severity of coronavirus disease 2019: a model-based analysis

…, A Dighe, JT Griffin, M Baguelin, S Bhatia… - The Lancet infectious …, 2020 - thelancet.com
Background In the face of rapidly changing data, a range of case fatality ratio estimates for
coronavirus disease 2019 (COVID-19) have been produced that differ substantially in …

Targeting of drugs and nanoparticles to tumors

E Ruoslahti, SN Bhatia, MJ Sailor - Journal of cell biology, 2010 - rupress.org
The various types of cells that comprise the tumor mass all carry molecular markers that are
not expressed or are expressed at much lower levels in normal cells. These differentially …

Three-dimensional tissue fabrication

VL Tsang, SN Bhatia - Advanced drug delivery reviews, 2004 - Elsevier
In recent years, advances in fabrication technologies have brought a new dimension to the
field of tissue engineering. Using manufacturing-based methods and hydrogel chemistries, …

[BOOK][B] Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand

…, N Imai, K Ainslie, M Baguelin, S Bhatia… - 2020 - scholar.harvard.edu
The global impact of COVID-19 has been profound, and the public health threat it represents
is the most serious seen in a respiratory virus since the 1918 H1N1 influenza pandemic. …

Biodegradable luminescent porous silicon nanoparticles for in vivo applications

…, L Gu, G Von Maltzahn, E Ruoslahti, SN Bhatia… - Nature materials, 2009 - nature.com
Nanomaterials that can circulate in the body hold great potential to diagnose and treat
disease 1 , 2 , 3 , 4 . For such applications, it is important that the nanomaterials be harmlessly …

Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues

…, AA Chen, PA Galie, X Yu, R Chaturvedi, SN Bhatia… - Nature materials, 2012 - nature.com
In the absence of perfusable vascular networks, three-dimensional (3D) engineered tissues
densely populated with cells quickly develop a necrotic core 1 . Yet the lack of a general …